Trial intelligence / Profile preview

Vitamin C Supplementation on GCF Total Oxidant Capacity in Smoker Patients With Periodontitis

NCT05009355Phase 1Unknown

Sponsor
Cairo University
Start
Jan 2019
Primary completion
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of ascorbic acid in periodontitis (2 arms), sponsored by Cairo University. Primary endpoint: Total Oxidant Capacity at 1 month. Status: unknown.

02

Drugs

ascorbic acid
03

Conditions

periodontitis

Beyond the preview

Go deeper on NCT05009355.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05009355.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call